Qure advances its Huntington’s program toward accelerated approval as PTC Therapeutics reports strong Phase 2 results. Learn ...

Jeffrey Epstein accuser Virginia Giuffre has died, according to family 5 questions HR legally cannot ask you in a job interview — and what to do if they're brought up Republican candidate John ...

This study presents an important finding on the alterations in the autophagic-lysosomal pathway in a Huntington's disease model ... and the result is shown in the bar graph. Statistical significances ...

Abstract: Freezing of Gait (FOG) is a significant symptom contributing to gait dysfunction in Parkinson’s disease (PD) patients ... We also propose a graph-based multimodal fusion framework (GMFF) to ...

Huntington disease activist Jimmy Pollard proudly shows off the “CURE-HD” vanity plate on his car in Lowell, Massachusetts (Photo by Larry Luxner) Jimmy Pollard is a former special education teacher ...

High dose and low dose AMT-130 demonstrated an 80% and 30% slowing of disease progression vs external control, respectively. The Food and Drug Administration has granted Breakthrough Therapy ...

LEXINGTON, Mass. and AMSTERDAM, April 17, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical ...

“Receiving Breakthrough Therapy designation underscores both the urgent need for effective treatments for Huntington’s disease and the encouraging interim data demonstrating that AMT-130 has ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Northern Scotland has one of the highest rates of Huntington’s disease in the world, a study has found. The number of people living in the area who have the gene that causes the condition has ...